Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management.
Mandalà
M
M
Haemostasis and Thrombosis Center, Department of Oncology and Hematology, Ospedali Riuniti, Bergamo, Italy.
Falanga
A
A
Roila
F
F
D005060:Europe / Q000453:epidemiology; D013502:General Surgery; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000150:complications*; D011379:Prognosis; D012307:Risk Factors; D055502:Secondary Prevention; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000517:prevention & control / Q000628:therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D014859:Warfarin